has announced a $10 million endowment gift from the to create a neuro-oncology and genomics research center.
The gift will create the Joseph Clayes III Research Center for Neuro-Oncology and Genomics, which will work to accelerate the translation of leading-edge genomic research into the prevention, diagnosis, treatment, and cures for pediatric brain cancer. To that end, income from the endowment will be allocated to three specific programs: the Joseph Clayes III Neuro-Oncology Research Fund, which will support research on the genomic foundation of childhood brain cancers and help scientists develop individualized approaches to treatment; the Joseph Clayes III Endowed Chair in Neuro-Oncology Research, which will enable Rady Children's to invest in top leadership talent with the knowledge and skills to lead advanced genomics research; and the Joseph Clayes III Neuro-Oncology Research Fellowship and Education Fund, which will enable promising young scientists to learn the best approaches in pioneering cancer research and prepare them to be future leaders in genomic medicine.
"By accelerating research, investing in top talent, and training future leaders in genomic medicine, this generous gift has the very real potential to benefit generations of children," said Donald Kearns, M.D., president and CEO of Rady Children's. "We thank the Clayes Trust for this inspiring example of visionary giving."
The late Joseph Clayes III was a real-estate investor, avocado rancher, and philanthropist who valued the importance of education, the arts, and helping children. "My uncle Joe had a passion for causes that help children — specifically those who face physical or mental challenges in their lives," said Trulette Clayes, Clayes' niece and co-chair of the Joseph Clayes III Charitable Trust. "This endowment has the potential to change the course of how children with cancer receive treatment."